406 related articles for article (PubMed ID: 8269448)
1. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
[TBL] [Abstract][Full Text] [Related]
2. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
3. [Survey of MRSA infection in Ibaraki-ken--Ibaraki Association for infectious diseases].
Hasegawa S; Yoshizawa Y; Nakai T; Sawahata T; Ishida H; Irokawa M; Iwata S; Goto A; Shinohara Y; Togawa S
Nihon Rinsho; 1992 May; 50(5):961-9. PubMed ID: 1507451
[TBL] [Abstract][Full Text] [Related]
4. [Bacteriological evaluations of combination therapies with minocycline and beta-lactams for methicillin-resistant Staphylococcus aureus. II. cefuzonam plus minocycline].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R
Jpn J Antibiot; 1992 Jun; 45(6):605-11. PubMed ID: 1507394
[TBL] [Abstract][Full Text] [Related]
5. [Combination effects of fosfomycin and other oral antimicrobial agents against methicillin-resistant Staphylococcus aureus].
Akiyama H; Yamada T; Shimoe K; Torigoe R; Kanzaki H; Arata J
Nihon Hifuka Gakkai Zasshi; 1990 Nov; 100(12):1257-61. PubMed ID: 2077154
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of methicillin-resistant Staphylococcus aureus (MRSA) infection].
Takezawa Y; Ohtake N; Okamura K; Shibata Y; Nakano K; Yamanaka H
Hinyokika Kiyo; 1994 Nov; 40(11):999-1003. PubMed ID: 7832086
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin.
Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M
J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650
[TBL] [Abstract][Full Text] [Related]
8. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
[TBL] [Abstract][Full Text] [Related]
9. [Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1994 Jun; 47(6):693-700. PubMed ID: 8072177
[TBL] [Abstract][Full Text] [Related]
10. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
[TBL] [Abstract][Full Text] [Related]
11. [Annual changes in isolation of MRSA in our department and chemotherapeutic effect of antibiotics including minocycline against postoperative infections of methicillin-resistant S. aureus].
Yokoyama T; Kodama T; Takesue Y; Fujimoto M; Murakami Y; Sewake H; Imamura Y; Okita M
Jpn J Antibiot; 1990 Jan; 43(1):131-8. PubMed ID: 2348549
[TBL] [Abstract][Full Text] [Related]
12. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
[TBL] [Abstract][Full Text] [Related]
13. [Antibacterial activities and electron microscopic studies of imipenem in combination with fosfomycin against methicillin and fosfomycin resistant strains of Staphylococcus aureus].
Saionji K; Shitara S; Kobayashi I
Jpn J Antibiot; 1990 Mar; 43(3):379-87. PubMed ID: 2374289
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
[TBL] [Abstract][Full Text] [Related]
15. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
Jpn J Antibiot; 1993 Feb; 46(2):123-9. PubMed ID: 8331772
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). I. Susceptibility distribution].
Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1990 Jun; 43(6):919-53. PubMed ID: 2122040
[TBL] [Abstract][Full Text] [Related]
17. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Soriano A; Marco F; MartÃnez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J
Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250
[TBL] [Abstract][Full Text] [Related]
18. [Antibacterial activity of imipenem in combination with ampicillin against methicillin-resistant strains of Staphylococcus aureus].
Saionji K; Shitara M; Miyake N; Inoue K; Kobayashi I
Jpn J Antibiot; 1990 Oct; 43(10):1685-97. PubMed ID: 2086811
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
[TBL] [Abstract][Full Text] [Related]
20. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]